trending Market Intelligence /marketintelligence/en/news-insights/trending/HRtIbO9d_Ik4YYhQJL28yw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Essa Pharma to raise $15M via equity offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Essa Pharma to raise $15M via equity offering

Canada's Essa Pharma Inc. launched an equity offering of 75 million units at 20 cents apiece, to raise gross proceeds of up to US$15 million.

Each unit will comprise one common share and an 18-month warrant to buy an additional stock for 22 cents.

Shares and warrants from the offering, which is expected to close by Dec. 21, will be listed on the TSX Venture Exchange and Nasdaq Capital Market.

Bloom Burton Securities Inc. is acting as sole Canada placement agent for the offering, with H.C. Wainwright & Co. serving as the sole U.S. placement agent.

The company granted Bloom Burton a 30-day overallotment option to buy up to an additional 15% of the units offered.

Essa Pharma plans to use net proceeds for the ongoing preclinical development of its Aniten compounds, payments on its outstanding debt, working capital and general corporate purposes.